Sep

20

2021

Does use of therapeutic low-molecular-weight heparin (LMWH) in patients with chronic liver disease/cirrhosis require monitoring?

By William Aird

A

Does use of therapeutic low-molecular-weight heparin (LMWH) in patients with chronic liver disease/cirrhosis require monitoring?

Generally no, unless the patient has underlying kidney disease or is pregnant.

Posted on September 20, 2021

Stay Updated

If you are interested in getting the latest articles from The Blood Project, enter your name and email

  • This field is for validation purposes and should be left unchanged.